KLOW Blend in Australia: BPC-157, TB-500, GHK-Cu & KPV Research Guide

The KLOW blend is a pre-formulated four-compound lyophilised research vial containing BPC-157, TB-500 (Thymosin Beta-4 fragment), GHK-Cu (copper peptide), and KPV. The vial contains 80mg total, with GHK-Cu at 50mg and BPC-157, TB-500, and KPV at 10mg each. This weighting reflects GHK-Cu's established role as the primary regenerative and anti-ageing compound in the blend. The formulation is designed for researchers studying multi-pathway tissue repair and inflammation biology who want to administer all four compounds from a single reconstituted preparation.

The name KLOW reflects the four compounds: KPV, Lauroyl-based (GHK-Cu), Originator peptide (BPC-157), and Wound healing (TB-500). Each has an independent mechanism, and their combination represents a broad-spectrum approach to the biology of tissue repair.

BPC-157 is a synthetic 15-amino acid peptide derived from a naturally occurring protein in gastric juice. It is one of the most extensively studied research peptides, with preclinical data covering tendon and ligament repair, angiogenesis, gastrointestinal healing, and neuroprotection.

Key mechanisms: VEGF upregulation (promoting new blood vessel formation), upregulation of growth hormone receptor expression in tendon fibroblasts, and modulation of the nitric oxide system. In the KLOW context, BPC-157 contributes localised tissue repair signalling and angiogenic support.

See the full BPC-157 research guide →

TB-500 is a synthetic analogue of the active region of Thymosin Beta-4, a 43-amino acid protein involved in actin regulation, cell migration, and wound healing. TB-500 promotes cell migration to injury sites, stimulates angiogenesis, and has been studied for anti-inflammatory effects in cardiac and musculoskeletal models.

In the KLOW context, TB-500 complements BPC-157 with systemic cell migration signalling, where BPC-157 tends toward localised repair effects, TB-500's actin-binding and migration-promoting activity supports broader tissue recruitment. The combination is the basis for the widely researched "Wolverine stack."

See the full TB-500 research guide → and BPC-157 + TB-500 stack guide →

GHK-Cu is a naturally occurring copper-binding tripeptide (Glycine-Histidine-Lysine complexed with copper) found in human plasma, urine, and saliva. It has been studied extensively for its role in wound healing, collagen synthesis stimulation, anti-inflammatory activity, and anti-oxidant effects.

In the KLOW context, GHK-Cu contributes collagen remodelling and skin/connective tissue repair biology, mechanistic areas not directly covered by BPC-157 or TB-500 alone. Research has also examined GHK-Cu's effects on gene expression, with studies showing modulation of hundreds of genes involved in tissue repair and inflammation.

See the full GHK-Cu research guide →

KPV is a tripeptide (Lysine-Proline-Valine) derived from the C-terminal sequence of alpha-melanocyte stimulating hormone (α-MSH). It has been studied for its anti-inflammatory properties, particularly in gastrointestinal inflammation models. Research has shown KPV acts on melanocortin receptors (MC1R, MC3R) to suppress inflammatory cytokine production, including TNF-α and IL-1β.

In the KLOW context, KPV contributes anti-inflammatory signalling via a melanocortin pathway distinct from the mechanisms of the other three compounds. This multi-pathway anti-inflammatory coverage is the key rationale for including KPV in the combination.

See the full KPV research guide →

The KLOW blend vial contains 80mg total (GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg, KPV 10mg) as a single lyophilised preparation in a 3mL vial. Reconstitute and store following the standard protocol, see our peptide reconstitution & storage guide (TB-500's longer peptide chain may require slightly more time to dissolve).

Compound-specific concentrations:

• With 2mL BAC water (recommended): GHK-Cu 25mg/mL (25,000mcg/mL) · BPC-157 5mg/mL · TB-500 5mg/mL · KPV 5mg/mL · total 40mg/mL
• With 2.5mL BAC water (maximum for 3mL vial): GHK-Cu 20mg/mL · BPC-157 4mg/mL · TB-500 4mg/mL · KPV 4mg/mL · total 32mg/mL

Store reconstituted vial at 2–8°C. Use within 28–30 days. Use the reconstitution calculator for draw volumes based on per-compound dosing.

The KLOW blend is available from OzPeps as a 80mg lyophilised vial with fast Australia-wide shipping and discreet packaging. View KLOW blend stock and pricing →

Individual compounds are also available separately for researchers who need to adjust component ratios independently, see the full OzPeps catalogue.

All KLOW blend products from OzPeps are supplied strictly for in-vitro laboratory and research purposes. Not TGA-approved. Not for human or animal consumption. Researchers are responsible for all applicable regulatory compliance.